Northern Trust’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.4M | Buy |
626,719
+53,443
| +9% | +$1.73M | ﹤0.01% | 1678 |
|
|
2026
Q1 | $18.7M | Buy |
573,276
+32,222
| +6% | +$1.04M | ﹤0.01% | 1721 |
|
|
2025
Q4 | $19M | Sell |
541,054
-16,215
| -3% | -$575K | ﹤0.01% | 1696 |
|
|
2025
Q3 | $14.6M | Buy |
557,269
+14,205
| +3% | +$424K | ﹤0.01% | 1893 |
|
|
2025
Q2 | $14.4M | Buy |
543,064
+4,428
| +0.8% | +$117K | ﹤0.01% | 1851 |
|
|
2025
Q1 | $13M | Buy |
538,636
+2,652
| +0.5% | +$83.8K | ﹤0.01% | 1893 |
|
|
2024
Q4 | $21.6M | Buy |
535,984
+54,871
| +11% | +$3.13M | ﹤0.01% | 1642 |
|
|
2024
Q3 | $30.5M | Sell |
481,113
-435,353
| -48% | -$25.5M | 0.01% | 1363 |
|
|
2024
Q2 | $48.6M | Sell |
916,466
-36,391
| -4% | -$2.39M | 0.01% | 1021 |
|
|
2024
Q1 | $78.1M | Buy |
952,857
+36,477
| +4% | +$1.62M | 0.01% | 734 |
|
|
2023
Q4 | $17.1M | Sell |
916,380
-11,182
| -1% | -$146K | ﹤0.01% | 1730 |
|
|
2023
Q3 | $10.3M | Buy |
927,562
+15,874
| +2% | +$227K | ﹤0.01% | 1984 |
|
|
2023
Q2 | $14.8M | Buy |
911,688
+739,868
| +431% | +$15.5M | ﹤0.01% | 1786 |
|
|
2023
Q1 | $2.86M | Buy |
171,820
+45,038
| +36% | +$465K | ﹤0.01% | 2783 |
|
|
2022
Q4 | $1.19M | Sell |
126,782
-14
| -0% | -$62 | ﹤0.01% | 3200 |
|
|
2022
Q3 | $345K | Hold |
126,796
| – | – | ﹤0.01% | 3630 |
|
|
2022
Q2 | $366K | Sell |
126,796
-522,075
| -80% | -$1.29M | ﹤0.01% | 3650 |
|
|
2022
Q1 | $1.95M | Sell |
648,871
-208,903
| -24% | -$749K | ﹤0.01% | 3120 |
|
|
2021
Q4 | $3.94M | Sell |
857,774
-115,733
| -12% | -$649K | ﹤0.01% | 2834 |
|
|
2021
Q3 | $6.11M | Sell |
973,507
-26,294
| -3% | -$162K | ﹤0.01% | 2605 |
|
|
2021
Q2 | $5.99M | Sell |
999,801
-1,043
| -0.1% | -$6.19K | ﹤0.01% | 2736 |
|
|
2021
Q1 | $6.33M | Sell |
1,000,844
-349,322
| -26% | -$2.46M | ﹤0.01% | 2596 |
|
|
2020
Q4 | $7.6M | Sell |
1,350,166
-37,379
| -3% | -$226K | ﹤0.01% | 2426 |
|
|
2020
Q3 | $8.08M | Sell |
1,387,545
-37,423
| -3% | -$258K | ﹤0.01% | 2236 |
|
|
2020
Q2 | $10.3M | Buy |
1,424,968
+624,386
| +78% | +$4.15M | ﹤0.01% | 2078 |
|
|
2020
Q1 | $3.75M | Sell |
800,582
-16,803
| -2% | -$103K | ﹤0.01% | 2470 |
|
|
2019
Q4 | $6.55M | Sell |
817,385
-11,716
| -1% | -$85.4K | ﹤0.01% | 2427 |
|
|
2019
Q3 | $5.7M | Buy |
829,101
+60,235
| +8% | +$447K | ﹤0.01% | 2471 |
|
|
2019
Q2 | $6.38M | Buy |
768,866
+11,916
| +2% | +$102K | ﹤0.01% | 2415 |
|
|
2019
Q1 | $7.52M | Buy |
756,950
+27,992
| +4% | +$234K | ﹤0.01% | 2320 |
|
|
2018
Q4 | $5.58M | Buy |
728,958
+113,995
| +19% | +$1.36M | ﹤0.01% | 2436 |
|
|
2018
Q3 | $10.7M | Buy |
614,963
+122,118
| +25% | +$1.45M | ﹤0.01% | 2216 |
|
|
2018
Q2 | $4.68M | Buy |
492,845
+413,892
| +524% | +$2.75M | ﹤0.01% | 2712 |
|
|
2018
Q1 | $345K | Buy |
78,953
+38,901
| +97% | +$215K | ﹤0.01% | 3665 |
|
|
2017
Q4 | $163K | Buy |
40,052
+23,090
| +136% | +$67.1K | ﹤0.01% | 3870 |
|
|
2017
Q3 | $32K | Hold |
16,962
| – | – | ﹤0.01% | 4114 |
|
|
2017
Q2 | $18K | Hold |
16,962
| – | – | ﹤0.01% | 4186 |
|
|
2017
Q1 | $25K | Hold |
16,962
| – | – | ﹤0.01% | 4131 |
|
|
2016
Q4 | $20K | Hold |
16,962
| – | – | ﹤0.01% | 4104 |
|
|
2016
Q3 | $24K | Hold |
16,962
| – | – | ﹤0.01% | 4087 |
|
|
2016
Q2 | $21K | Buy |
+16,962
| New | +$22.4K | ﹤0.01% | 4113 |
|
Other funds holding VKTX
Northern Trust's VKTX Position: Q2 2026 in Review
Northern Trust increased its Viking Therapeutics (VKTX) stake by 9.3% in Q2 2026, buying an estimated $1.73M and bringing the position to 626,719 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1678.
Northern Trust first reported a position in VKTX in Q2 2016 and has held it in 41 quarters since. The position peaked at $78.1M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Northern Trust held 626,719 shares of Viking Therapeutics worth $24.4M as of Q2 2026.
- Northern Trust bought 53,443 Viking Therapeutics shares in Q2 2026, an estimated $1.73M.
- Viking Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1678 holding.
- Northern Trust first reported a position in Viking Therapeutics in Q2 2016 and has held it in 41 quarters since.
- Northern Trust's Viking Therapeutics position peaked at $78.1M in Q1 2024.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.